Objective: To compare short-term complications and long-term survival outcomes between muscle-sparing thoracotomy (MST) and video-assisted thoracic surgery (VATS) groups using a propensity-score matching process.
See Editorial Commentary page 1430.
Lung cancer is among the most frequently diagnosed cancers worldwide, with the highest mortality rate among men and the second highest mortality rate among women. 1 Lobectomy and a systematic lymph node dissection can be performed using videoassisted thoracic surgery (VATS) or muscle-sparing thoracotomy (MST) as a minimally invasive surgical procedure.
Several studies have reported that compared with open thoracotomy, VATS had lower rates of postoperative complications and a shorter hospital stay in patients with early stage lung cancer. [2] [3] [4] [5] [6] [7] [8] In addition, several studies have Intervention Therapy, Fudan University Shanghai Cancer Center; and reported that both VATS and open thoracotomy had equivalent long-term survival outcomes. 7, 9 However, only a few studies in the literature focused on the comparison of short-term postoperative complications and long-term survival outcomes between VATS and MST. Thus, this question still needs further clarifying and more evidence focusing on this topic is needed. 10 We retrospectively reviewed 1083 patients with cT1 N0 M0 lung cancer from January 2009 to December 2014 from Fudan University Shanghai Cancer Center to compare the short-term postoperative outcomes and long-term survival outcomes between VATS and MST lobectomy. A propensity-score matching process was used to balance significant preoperative covariates and minimize potential biases.
PATIENTS AND METHODS Patients
One thousand eighty-three patients with cT1 N0 M0 lung cancer during the period January 2009 to December 2014 treated at Fudan University Shanghai Cancer Center who had MST or VATS lobectomy were retrospectively included in this study. Patients who had a previous history of malignancy, underwent a neoadjuvant therapy, or had stage IV disease were excluded ( Figure 1 ). To determine the clinical stage before surgery, patients received enhanced chest computed tomography (CT) scanning and positron emission tomography-CT scanning. Those patients who did not receive positron emission tomography-CT scanning received an enhanced brain CT or magnetic resonance imaging, whole-body bone scanning, and abdominal CT or ultrasonography. Fiber optic bronchoscopy was routinely performed. Patients were grouped into the MST group or VATS group according to the surgical procedure they underwent. Informed consents of included patients were waived because this was a retrospective study. This study was approved by the Committee for Ethical Review of Research (Fudan University Shanghai Cancer Center Institutional Review Board No. 090977-1).
Surgical Approaches
Both MST and VATS were performed under general anesthesia and single-lung ventilation using a double-lumen endobronchial tube. Patients were placed in a lateral decubitus position. The MST procedure was started with a posterolateral 7-to 13-cm long skin incision at the fourth or fifth intercostal space. The latissimus dorsi was exposed and retracted posteriorly and the serratus anterior muscle was split along its muscle fibers. The VATS procedure was performed using a 3-port technique. The observation port was placed initially at the sixth or seventh intercostal space on the middle axillary line. The utility port was placed at the seventh or eighth intercostal space on the posterior axillary line. And an additional 5-to 7-cm incision was made along the fourth intercostal space for taking out the resected lobe. Lobectomy and a systematic mediastinal lymph node dissection were performed in both MST and VATS groups. The systematic lymph node dissection was performed according to the tumor location. Lymph node stations 7, 8, 10, and 11 were routinely dissected regardless of the tumor location. Additionally, for a tumor located in the left upper lobe, lymph node stations 4, 5, and 6 were routinely dissected. For a tumor located in the left lower lobe, lymph node stations 4, 5, 6, and 9 were routinely dissected. For a tumor located in the right upper lobe, lymph node stations 2 and 4 were routinely dissected, and station 3 was optionally dissected. For a tumor located in the right middle lobe, lymph node stations 2 and 4 were routinely dissected, and station 3 was optionally dissected. For a tumor located in the right lower lobe, lymph node stations 2, 4, and 9 were routinely dissected, and station 3 was optionally dissected (Video 1). Resected tumors and lymph nodes were reviewed by pathologists to determine the pathologic stage, according to the current seventh edition of the TNM staging system of lung cancer. 11 Regional lymph node stations were defined as Mountain 
Follow-up Protocol
Patient follow-up was a part of our routine clinical practice and started the day he or she received surgery. The start point was considered the day he or she received surgery. After surgery, patients came to the hospital to undergo a routine examination, including chest CT, brain MRI, and abdominal ultrasonography every 3 months for the first 2 years after surgery, every 6 months for the next 2 years after surgery, and once a year from then on. A telephone follow-up would be made if the patient did not come to the clinic. The follow-up work started during January 2009 and ended during June 2016. Overall survival (OS) was considered the time between the day of surgery and the day of death from any cause. Patients with no event were censored at the date of their last follow-up. Recurrence-free survival (RFS) was considered the time between the day of surgery and the day of disease recurrence. Patients who died before disease recurrence were censored on the date of their last alive follow-up, and patients with no event were censored on the date of their last follow-up.
Propensity-score Matching
To adjust for significant preoperative covariates between the 2 groups, a propensity-score matching process using a logistic regression model was used to reduce potential biases. Patient baseline clinical characteristics, including gender; age; body mass index (BMI); smoking status; percent of forced expiratory volume in 1 second predicted (FEV1%); percent of maximum voluntary ventilation predicted (MVV%); tumor location; central or peripheral location on chest CT scan; tumor size on chest CT scan; and preoperative comorbidities, including chronic bronchitis, emphysema, asthma, bronchiectasis, tuberculosis, pneumonia, coronary artery disease, hypertension, and diabetes mellitus were considered as covariates for propensity-score matching. The propensity-score matching process was performed using the nearest method, with the number of patients of each group being 1:1. Caliper was set 0.005. Baseline standardized mean differences were calculated before and after propensity-score matching.
Statistical Analyses
Patients' clinical and pathologic characteristics before and after propensity-score matching, including gender, age, BMI, smoking status, FEV1%, MVV%, tumor location, central or peripheral location on chest CT scan, tumor size on chest CT scan, clinical T stage, preoperative comorbidities, duration of surgery, number of resected lymph nodes, number of resected lymph node stations, chest tube dwelling days, chest tube output, total hospital stay, pathologic tumor size, resection completeness, pathology, pathologic stage, and postoperative complications were recorded. Student t test was used to compare continuous variables between the MST and VATS groups, whereas Pearson c 2 test and Fisher exact test were used to compare categorical variables wherever applicable. Kaplan-Meier survival curves for both groups were used to depict the RFS and OS before and after propensity-score matching, and log-rank test was used to compare the survival outcomes of the 2 groups. Patients who died before discharge were excluded from the survival analysis. Moreover, to identify whether the surgical approach was the independent prognostic factor, multivariable analyses for overall survival using Cox regression model adjusting for patient gender, age, BMI, smoking status, FEV1%, MVV%, tumor location, central or peripheral location on chest CT scan, tumor size on chest CT scan, and preoperative complication, along with the surgical approach, were performed both before and after propensity-score matching. All statistical analyses were performed using SPSS (version 22.0, IBM-SPSS Inc, Armonk, NY) and R (version 3.3.0, R Foundation for Statistical Computing, Vienna, Austria). Survival curves were depicted using GraphPad Prism (version 6.01, GraphPad Software Inc, La Jolla, Calif).
RESULTS
Before propensity-score matching, 560 of the 1083 patients were in the MST group, and 523 were in the VATS group. Their baseline clinical characteristics before propensity-score matching ae shown in Table 1 . There were significant differences in patient gender (P < .001), age (P ¼ .001), smoking status (P<.001), central or peripheral location on chest CT scan (P <.001), tumor size on chest CT scan (P <.001), clinical T stage (P <.001), and preoperative chronic bronchitis between the MST and VATS groups (Table 1) . For short-term surgical outcomes, compared with patients in the MST group, patients in the VATS group had more surgical time (98.8 AE 34.3 vs 77.8 AE 26.1; P < .001), fewer lymph nodes resected (12.6 AE 6.8 vs 18.2 AE 8.7; P <.001), fewer lymph node stations resected (4.2 AE 1.3 vs 5.1 AE 1.5; P <.001), fewer chest tube dwelling days (3.7 AE 2.3 vs 4.8 AE 3.4; P < .001), less chest tube output, (653.2 AE 531.6 vs 981.8 AE 830.3; P < .001), fewer days of hospital stay (6.1 AE 3.3 vs 7.3 AE 4.5; P < .001), and a pathologically confirmed smaller tumor size (1.8 AE 0.9 vs 2.2 AE 0.9; P <.001). In addition, the comparison of pathologic types between the 2 groups were significantly different (P <.001). More patients in the MST group had squamous cell carcinoma (14.1% vs 4.8%), whereas more patients in the VATS group had adenocarcinoma (75.0% vs 89.3%). Moreover, we compared the pathologic stage of patients between both groups. In general, patients in the MST group had higher pathologically confirmed T, N, and TNM stages, as shown in Table 2 . Additionally, nodal upstaging was more frequently seen in the MST group (24.1% vs 12.6%; P <.001). Finally, we compared the postoperative complications between these 2 groups, and results showed that patients in the VATS group had fewer postoperative complications than patients in the MST group (4.6% vs 8.2%; P ¼ .015). For each individual complication, our data showed that there was a higher rate of chylothorax in the MST group (2.5% vs 0.4%; P ¼ .004) ( Table 2) .
After propensity-score matching, there were 482 patients, with 241 patients in either group. And there were no significant differences in compared baseline clinical characteristics, as shown in Table 3 . The distribution of propensity scores across 2 groups was demonstrated in Figure  E1 . For short-term surgical outcomes, compared with patients in the MST group, patients in the VATS group had more surgical time (98.8 AE 34.5 vs 78.0 AE 26.0; P < .001), fewer lymph nodes resected (12.6 AE 6.9 vs 17.9 AE 8.1; P <.001), fewer lymph node stations resected (4.3 AE 1.4 vs 5.1 AE 1.6; P<.001), fewer chest tube dwelling days (3.7 AE 2.3 vs 4.8 AE 3.7; P < .001), less chest tube output (672.2 AE 564.9 vs 942.6 AE 781.3, P < .001), and fewer days of hospital stay (6.0 AE 3.6 vs 7.1 AE 3.8; P ¼ .002). There were no significant differences in pathologically confirmed tumor size; pathologic type; nodal upstaging; and pathologically confirmed T, N, and TNM stages. However, there was still a significant difference of postoperative complications between these 2 groups (9.1% vs 3.3%; P ¼ .008), and a higher rate of chylothorax for the MST group (2.5% vs 0%; P ¼ .030).
To compare the long-term survival outcomes between the MST and VATS groups, we performed survival analyses using Kaplan-Meier survival curves and log-rank tests. The median follow-up time was 29.0 months for all patients and 29.1 months for matched patients. In an unadjusted comparison, VATS showed superior recurrence-free survival (P<.001) and overall survival (P<.001); however after adjusting for patient factors (eg, gender and age), there was no difference (P ¼ .152 for RFS and P ¼ .639 for OS) (Figures 2-5) .
To see whether surgical approach was an independent prognostic factor, we performed a multivariable analysis for overall survival using Cox regression hazards model before and after propensity-score matching. The Cox regression hazards model was adjusted for patient gender, age, BMI, smoking status, FEV1%, MVV%, tumor location, central or peripheral location on chest CT scan, tumor size, preoperative complications, and surgical approach. In the unmatched analysis, age, tumor size on chest CT scan, and surgical approach were shown to be independent prognostic factors for patients' OS (Table 4) , whereas in the matched analysis, age, tumor size on chest CT scan, and whether there was a preoperative complication were shown to be independent prognostic factors for patients' OS (Table 5) .
DISCUSSION
Minimally invasive approaches are widely used in patients with early stage lung cancer. VATS has been shown to be a feasible minimally invasive surgical approach and associated with short hospital stay, lower rates of postoperative complications, and less pain by a number of studies in the past 2 decades. [2] [3] [4] [5] [6] [7] [8] [13] [14] [15] [16] Several studies also reported that VATS and open thoracotomy had equivalent long-term survival outcomes. 4, 7, 17 There was also a randomized controlled trial 18 for lymph node dissection (American College of Surgeons Oncology Group Z0030), which also made a secondary analysis comparing long-term surgical outcome between open lobectomy and VATS using propensity-score matching. In their comparison between 686 patients in the open thoracotomy group and 66 patients in the VATS group, both disease-free survival and overall survival showed no significant difference. However, the number of studies focusing on the comparison between VATS and the less invasive muscle-sparing thoracotomy in the literature is limited. Kuritzky and colleagues 19 conducted a propensity-score matched analysis and found that compared with MST lobectomy, VATS lobectomy for clinical stage I non-small cell lung cancer had similar short-term and long-term outcomes. More data are needed to have this issue better understood. Based on this background, we conducted this propensityscore matched, nonrandomized, retrospective study. There were several propensity-score matched studies focusing on the topic of nodal upstaging in the literature. Medbery and colleagues 20 demonstrated that nodal upstaging was more common after open thoracotomy than after VATS. However, in an academic or research facility, there was no difference between the 2 groups. Moreover, Boffa and colleagues 21 found that upstaging from N0 to N1 was more common in the open thoracotomy group, whereas upstaging from N0 to N2 was similar in the 2 groups. Our results demonstrate that before propensity-score matching, nodal upstaging was more commonly seen in the MST group than in the VATS group. However, after propensity-score matching, there was no longer a significant difference (Tables 2 and 6 ). These results suggested that the differences were due to tumor and patient characteristics, rather than the technique in patients with a cT1 N0 M0 lung cancer. In our study, we found that compared with the minimally invasive MST lobectomy, VATS lobectomy was associated with shorter hospital stay, fewer chest tube dwelling days, less chest tube output, and fewer postoperative complications both before and after the propensity-score matching process, which were consistent with several previous studies. [2] [3] [4] [5] [6] [7] [8] [13] [14] [15] [16] Moreover, the number of resected lymph nodes and lymph node stations were fewer for VATS lobectomy, which might correlate with the lower rate of postoperative chylothorax (Tables 2 and 6 ). Additionally, our study found that after adjusting for the preoperative covariates, although the number of resected lymph nodes and lymph node stations of VATS group were fewer, there was no significant difference of nodal upstaging status between the 2 surgical groups. This interesting finding suggests that when controlled for other preoperative confounders, MST lobectomy itself does not show a significant superiority on assessing nodal status over VATS lobectomy in patients with early stage lung cancer, although more lymph nodes and lymph node stations were resected using the MST approach. This leads to another question that is still unclear: How many lymph nodes resected is enough? 22, 23 Intuitively, the more lymph nodes resected, the lower false negative rate should we get. But our study shows that different surgical approaches result in different lymph nodes resected, but their long-term RFS and OS were equivalent. Although this topic is beyond the objective of this article, this interesting finding is still worth mentioning.
For long-term survival outcomes, our results demonstrated that in an unadjusted comparison, VATS showed superior RFS and OS; however, after adjusting for patient factors (eg, gender and age), there was no significant difference. These results suggest VATS and MST lobectomy have equivalent long-term survival outcomes, which is consistent with several studies discussing the comparison between VATS and open thoracotomy. 4, 7, 17 These findings showed that it was the tumor and patients' characteristics that drove the differences in RFS and OS, rather than the surgical approach itself. Moreover, as shown in Table 5 , surgical approach was not an independent prognostic factor for patients' OS. Instead, tumor size on CT scan, patients' age, and whether a patient had preoperative complications were shown to be independent prognostic factors for patients' OS.
The unique advantage of our study is that we have a large number of patients. With the help of this large population, we were able to perform statistical analyses in enough patients after discarding hundreds of them in the propensity-score matching process, even if we narrowed the caliper to 0.005, to make our study cohort very homogeneous. The analysis of this large number of patients gives us a straightforward, precise, and reliable conclusion.
There are also limitations. The propensity-score matching process using a logistic regression model was reported to be effective to adjust for significant confounders and reduce potential biases in retrospective studies; however, unlike randomized controlled trials, it has the limitation that it does not reduce the biases caused by unobserved covariates. 24, 25 In our daily practice, we tend not to perform VATS on those patients with worse disease (eg, patients with a bigger tumor on the chest CT scan or patients who smoke). In our experience, patients in the MST group had more exudates and pleural adhesion and the number of lymph nodes they had per se was greater than that of their counterparts in the VATS group. Some lymph node stations dissected were pathologically confirmed as inflammatory lesions that were not counted as a dissected lymph node station, and this phenomenon more commonly occurred when we performed VATS procedures. Undoubtedly, the best evidence should come from a large, randomized controlled trial. A retrospective study using propensity-score matching should never be considered as the substitute for a prospective study. Another issue that was not discussed in our article is alternative approaches of open thoracotomy, such as retracting the latissimus dorsi anteriorly without splitting the serratus anterior muscle, and rib shingling. Compared with these 2 approaches, retracting the latissimus dorsi posteriorly with the serratus anterior muscle split along its muscle fibers, as described in this article, has the advantage of a smaller incision, less bleeding, and shorter recovery time. The issue of the comparison between VATS lobectomy and minimally invasive MST lobectomy still needs more 
